A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Immunovant, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 5,294 shares of IMVT stock, worth $145,637. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,294
Previous 4,360 21.42%
Holding current value
$145,637
Previous $115,000 26.09%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$27.51 - $27.51 $25,694 - $25,694
934 Added 21.42%
5,294 $145,000
Q2 2024

Jul 30, 2024

SELL
$25.1 - $31.61 $1.69 Million - $2.13 Million
-67,428 Reduced 93.93%
4,360 $115,000
Q1 2024

May 01, 2024

BUY
$30.27 - $43.79 $1.08 Million - $1.56 Million
35,589 Added 98.31%
71,788 $2.32 Million
Q4 2023

Jan 24, 2024

SELL
$31.31 - $44.19 $37,634 - $53,116
-1,202 Reduced 3.21%
36,199 $1.53 Million
Q3 2023

Oct 26, 2023

BUY
$18.55 - $39.96 $19,644 - $42,317
1,059 Added 2.91%
37,401 $1.44 Million
Q2 2023

Aug 10, 2023

SELL
$14.2 - $23.75 $540,026 - $903,212
-38,030 Reduced 51.13%
36,342 $689,000
Q1 2023

May 04, 2023

BUY
$15.27 - $19.72 $787,825 - $1.02 Million
51,593 Added 226.49%
74,372 $1.15 Million
Q4 2022

Feb 09, 2023

BUY
$6.59 - $17.75 $21,134 - $56,924
3,207 Added 16.39%
22,779 $404,000
Q3 2022

Nov 10, 2022

BUY
$3.93 - $6.37 $19,807 - $32,104
5,040 Added 34.68%
19,572 $109,000
Q2 2022

Jul 26, 2022

BUY
$3.38 - $5.65 $49,118 - $82,105
14,532 New
14,532 $57,000

Others Institutions Holding IMVT

About Immunovant, Inc.


  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.